Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.98 (+9.56%) Sep 12
At Loss
P/B:
1.48
Market Cap:
€ 89.48M ($ 99.20M)
Enterprise V:
€ 25.50M ($ 28.28M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Relmada Therapeutics Inc (STU:4E2) Stock News, Headlines & Updates